Mereo BioPharma (UK) Probability of Future Stock Price Finishing Over 2.48
| 0A9G Stock | 3.55 0.15 4.41% |
Mereo |
Mereo BioPharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mereo BioPharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mereo BioPharma Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mereo BioPharma generated a negative expected return over the last 90 days | |
| Mereo BioPharma has high historical volatility and very poor performance | |
| Mereo BioPharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1000 K. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 936 K. | |
| Mereo BioPharma generates negative cash flow from operations | |
| About 68.0% of the company shares are owned by institutions such as pension funds |
Mereo BioPharma Technical Analysis
Mereo BioPharma's future price can be derived by breaking down and analyzing its technical indicators over time. Mereo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mereo BioPharma Group. In general, you should focus on analyzing Mereo Stock price patterns and their correlations with different microeconomic environments and drivers.
Mereo BioPharma Predictive Forecast Models
Mereo BioPharma's time-series forecasting models is one of many Mereo BioPharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mereo BioPharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Mereo BioPharma Group
Checking the ongoing alerts about Mereo BioPharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mereo BioPharma Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mereo BioPharma generated a negative expected return over the last 90 days | |
| Mereo BioPharma has high historical volatility and very poor performance | |
| Mereo BioPharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1000 K. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 936 K. | |
| Mereo BioPharma generates negative cash flow from operations | |
| About 68.0% of the company shares are owned by institutions such as pension funds |
Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.